- Home
- STBA vs PRAX Comparison
STBA vs PRAX Comparison
Compare STBA & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STBA
- PRAX
- Stock Information
- Founded
- STBA 1902
- PRAX 2015
- Country
- STBA United States
- PRAX United States
- Employees
- STBA N/A
- PRAX N/A
- Industry
- STBA Major Banks
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- STBA Finance
- PRAX Health Care
- Exchange
- STBA Nasdaq
- PRAX Nasdaq
- Market Cap
- STBA 1.5B
- PRAX 1.4B
- IPO Year
- STBA N/A
- PRAX 2020
- Fundamental
- Price
- STBA $39.36
- PRAX $74.49
- Analyst Decision
- STBA Hold
- PRAX Strong Buy
- Analyst Count
- STBA 1
- PRAX 9
- Target Price
- STBA $41.00
- PRAX $149.00
- AVG Volume (30 Days)
- STBA 166.5K
- PRAX 388.8K
- Earning Date
- STBA 04-17-2025
- PRAX 03-04-2025
- Dividend Yield
- STBA 3.46%
- PRAX N/A
- EPS Growth
- STBA N/A
- PRAX N/A
- EPS
- STBA 3.41
- PRAX N/A
- Revenue
- STBA $383,756,000.00
- PRAX $1,605,000.00
- Revenue This Year
- STBA N/A
- PRAX N/A
- Revenue Next Year
- STBA $5.82
- PRAX N/A
- P/E Ratio
- STBA $11.55
- PRAX N/A
- Revenue Growth
- STBA N/A
- PRAX N/A
- 52 Week Low
- STBA $28.83
- PRAX $33.01
- 52 Week High
- STBA $45.79
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- STBA 49.06
- PRAX 42.80
- Support Level
- STBA $39.43
- PRAX $76.00
- Resistance Level
- STBA $40.90
- PRAX $91.83
- Average True Range (ATR)
- STBA 1.46
- PRAX 6.29
- MACD
- STBA -0.01
- PRAX -1.10
- Stochastic Oscillator
- STBA 51.20
- PRAX 2.42
About STBA S&T Bancorp Inc.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. It has one reporting unit, Community Banking. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.